Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support


Urology Laser Market size was valued at USD 1.05 Billion in 2022 and is poised to grow from USD 1.12 Billion in 2023 to USD 1.86 Billion by 2031, at a CAGR of 6.5% during the forecast period (2024-2031).

The urology laser market presents a notably competitive landscape, characterized by the presence of well-established industry leaders vying for market supremacy, while innovative newcomers are determined to establish their unique positions. Prominent players in the field consistently allocate resources towards research and development efforts to augment their product portfolios and uphold their competitive advantage. 'Lumenis Ltd. (Israel)', 'Boston Scientific Corporation (United States)', 'Olympus Corporation (Japan)', 'Quanta System S.p.A. (Italy)', 'JenaSurgical GmbH (Germany)', 'Cook Medical LLC (United States)', 'Dornier MedTech GmbH (Germany)', 'Biolitec AG (Germany)', 'IPG Photonics Corporation (United States)', 'Convergent Laser Technologies (United States)', 'Sisurgical Inc. (United States)', 'Richard Wolf GmbH (Germany)', 'ForTec Medical Inc. (United States)', 'S.R.L. Medica (Italy)', 'El.En. S.p.A. (Italy)', 'Aoteng Medical Ltd. (China)', 'StarMedTec GmbH (Germany)', 'Excel Hoya (United States)', 'Clearwater Clinical Limited (Canada)', 'Advanced Optowave Corporation (United States)'

The increasing incidences of urological disorders such as kidney stones, benign prostatic hyperplasia (BPH), urolithiasis, and non-muscle-invasive bladder cancer (NMIBC) is a primary driver of the urology laser market. As the occurrence of these disorders rises more , the demand for laser-based treatments will also rise.

Personalized Treatment Procedures: The urology laser industry is seeing growth in personalized treatment. Healthcare professionals are progressively adjusting treatment programs to meet the unique demands of each patient, taking into account their age, current state of health, and particular urological problem. This pattern is encouraging the creation of laser treatments that are more exact and patient-focused.

North America has emerged as the dominant force in the urology laser market, commanding a significant revenue share of 32%. This robust market presence is attributed to the increasing prevalence of urolithiasis, benign prostatic hyperplasia (BPH), and various other urology-related disorders within the region. Notably, an interesting statistic from the National Center for Biotechnology Information (NCBI) highlights that 50% of patients in the United States are afflicted with urolithiasis, a condition often linked to excessive calcium and fluid consumption, a significant contributing factor to the formation of urinary stones. Moreover, the growth of this market segment is further accelerated by ongoing technological advancements in urology laser equipment. For example, companies like Lumenis have introduced cutting-edge MOSES technology, revolutionizing holmium laser lithotripsy and BPH treatments. These technological innovations are playing a pivotal role in stimulating demand for urology lasers in the region.

Feedback From Our Clients

Global Urology Laser Market

Product ID: SQMIG35A2497